Canada’s Valeant said on April 22 that it and activist investor Bill Ackman made an unsolicited $47 billion bid to buy Allergan.

Allergan, which makes the popular anti-wrinkle treatment Botox, also said on Monday it expected to increase its earnings per share by 20-25 percent and continue to generate double digit revenue growth in 2015. (Reporting by Esha Dey in Bangalore; Editing by Maju Samuel)